Furthermore, EBV might interfere with apoptotic pathways: in EBV+ PTLD, the expression level of proapoptotic protein Bim, a critical regulator of lymphocyte survival, is lower when compared to EBV- PTLDs (Ghigna et al., 2013). Here, BCL2L11 is linked to post-transplant lymphoproliferative disease.